EUVIMEDEUVIMED entdecken
Crossref

Machine Learning-Enhanced Cerebrospinal Fluid N-Glycome for the Diagnosis and Prognosis of Primary Central Nervous System Lymphoma

Tao Liu iD, Huaizu Guo iD, Qing Li, Kun Chen, Jin Xu, Yan Ma, Zhiguang Lin, Xinli Zhou, Bobin Chen

Journal of Proteome Research · 02.05.2025 · 24 (5) · 2369-2385

DOI: 10.1021/acs.jproteome.4c01006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 22.04.2025. Verfasst von Tao Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Huashan Hospital, Fudan University, Shanghai 200040, China. Hauptthemen laut MEDLINE: Machine Learning, Central Nervous System Neoplasms, Lymphoma, Glycomics. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningCentral Nervous System NeoplasmsLymphomaGlycomicsBiomarkers, TumorHumansFemaleMalePrognosisMiddle AgedAgedAdultNomogramsProportional Hazards Models

Stichwörter der Autor:innen

cerebrospinal fluid N-glycomicsdiagnosismachine learningprimary central nervous system lymphoma (PCNSL)prognosis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Oncology, Huashan Hospital, Fudan University, Shanghai 200040, China.
  • State Key Laboratory of Macromolecular Drugs and Large-scale Preparation, Wenzhou Medical University, Wenzhou 325015, China.
  • NMPA Key Laboratory for Quality Control of Therapeutic Monoclonal Antibodies, Shanghai 201203, China.
  • School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, Liaocheng 252000, China.
  • Shanghai Zhangjiang Biotechnology Co., Ltd, Shanghai 201203, China.
  • Department of Hematology, Huashan Hospital, Fudan University, Shanghai 200040, China.

ORCID-Profile: Tao Liu, Huaizu Guo

Förderung

  • National Natural Science Foundation of China
  • Shandong Provincial Natural Science Foundation
  • National Key R&D Program of China
  • Municipal Hospital Diagnosis and Treatment Technology Promotion and Optimal Management Research Program of Shanghai Shenkang Hospital Development Centre

Zitieren

APA

Liu, T., Guo, H., Li, Q., Chen, K., Xu, J., Ma, Y., Lin, Z., Zhou, X., & Chen, B. (2025). Machine Learning-Enhanced Cerebrospinal Fluid N-Glycome for the Diagnosis and Prognosis of Primary Central Nervous System Lymphoma. Journal of Proteome Research, 24(5), 2369-2385. https://doi.org/10.1021/acs.jproteome.4c01006

Vancouver

Liu T, Guo H, Li Q, Chen K, Xu J, Ma Y, et al. Machine Learning-Enhanced Cerebrospinal Fluid N-Glycome for the Diagnosis and Prognosis of Primary Central Nervous System Lymphoma. Journal of Proteome Research. 2025;24(5):2369-2385. doi:10.1021/acs.jproteome.4c01006

BibTeX
@article{Liu2025,
  author = {Liu, Tao and Guo, Huaizu and Li, Qing and Chen, Kun and Xu, Jin and Ma, Yan and Lin, Zhiguang and Zhou, Xinli and Chen, Bobin},
  title = {Machine Learning-Enhanced Cerebrospinal Fluid N-Glycome for the Diagnosis and Prognosis of Primary Central Nervous System Lymphoma},
  journal = {Journal of Proteome Research},
  year = {2025},
  volume = {24},
  number = {5},
  pages = {2369--2385},
  doi = {10.1021/acs.jproteome.4c01006}
}
Kostenlos starten →